Skip to content

Clinical trials

Phase 4 Renal Insufficiency trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency Phase: Phase 4 Country / region: United States Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20043
20054
20063
20081
20095
20101
20113
20122
20132
20142
20151
20161
20171
20181
20192
20213
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated12
Withdrawn5
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GE Healthcare3
Massachusetts General Hospital3
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2
George Washington University2
Loyola University2
Watson Pharmaceuticals2
Astellas Pharma Inc1
Baylor College of Medicine1
Emerald Clinical Inc.1
Fresenius Medical Care North America1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency40
Renal Insufficiency, Chronic11
Kidney Failure, Chronic6
Diabetes Mellitus, Type 25
Hepatitis C5
Anemia, Iron-Deficiency3
Diabetes Mellitus3
Hyperparathyroidism, Secondary3
Hyperphosphatemia3
Anemia2

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.